CERo Therapeutics Holdings, Inc. Warrants

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CEROW and buy or sell other stocks, ETFs, and their options commission-free!

About CEROW

CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. 

CEO
Christopher B. Ehrlich, MBA
CEOChristopher B. Ehrlich, MBA
Employees
—
Employees—
Headquarters
Oakland, California
HeadquartersOakland, California
Founded
Founded
Employees
—
Employees—

CEROW Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
26.98K
Average volume26.98K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$0.0623
52 Week high$0.0623
52 Week low
$0.0031
52 Week low$0.0031

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.